Table 3.
Name–year | Type of study | Intervention: N | Persistent/recurrent abscessa | Additional intervention | Complication (number of patients) |
---|---|---|---|---|---|
Clark 2011 [3] | Historical cohort | Surgical: 12 | 3 (25) | Surgical: 3 | Recurrent abscess: 2 |
Fistula: 1 | |||||
Scrotal abscess: 1 | |||||
Dhaou 2010 [4] | Historical cohort | Antibiotics: 7 | 1 (15) | Surgical: 1 | Recurrent abscess: 1 |
Radiological: 1 | 1 (100) | Surgical: 1 | Persistent abscess: 1 | ||
Surgical: 6 | 0 | ||||
Forgues 2007 [6] | Historical cohort | Antibiotics: 22 | 0 | ||
Radiological: 1 | 0 | ||||
Surgical: 3 | 1 (33) | Surgical: 1 | Persistent abscess: 1 | ||
Dobremez 2003 [5] | Historical cohort | Antibiotics: 11 | 1 (9) | Surgical: 1 | Recurrent abscess: 1 |
Gallbladder stone: 1 | |||||
Surgical: 11 | 2 (22) | Antibiotics: 6 | Fistula: 4 | ||
Surgical: 1 | Recurrent abscess: 2 | ||||
Gas gangrene: 1 | |||||
Intra-peritoneal bleeding: 1 | |||||
Okoye 1998 [14] | Historical cohort | Antibiotics: 23 | 2 (9) | Surgical: 1 | Persistent abscess: 2 |
Percutaneous: 1 | Pleural effusion: 1 | ||||
Gorenstein 1994 [7] | Historical cohort | Antibiotics: 10 | 3 (30) | Percutaneous: 2 | Persistent abscess: 3 |
Antibiotics: 1 |
aData is displayed as: Number of patients (percentage)